BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33457635
Number of visits today
3854
Number of downloads
16640823
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Jovanović JĐ, Antonijević M, El-Emam AA, Marković Z. Comparative MD Study of Inhibitory Activity of Opaganib and Adamantane-Isothiourea Derivatives toward COVID-19 Main Protease Mpro. ChemistrySelect 2021;6:8603-10. [PMID: 34909459 DOI: 10.1002/slct.202101898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Pauly I, Kumar Singh A, Kumar A, Singh Y, Thareja S, Kamal MA, Verma A, Kumar P. Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment. Curr Pharm Des 2022;28:3677-705. [PMID: 36345244 DOI: 10.2174/1381612829666221107123841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Palanisamy K, Rubavathy SME, Prakash M, Thilagavathi R, Hosseini-zare MS, Selvam C. Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach. RSC Adv 2022;12:3687-95. [DOI: 10.1039/d1ra08604a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Herrmann L, Hahn F, Wangen C, Marschall M, Tsogoeva SB. Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection Models. Chemistry 2021;:e202103861. [PMID: 34859926 DOI: 10.1002/chem.202103861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345